Amgen
Trade Amgen 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About AMGN
Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K.
AMGN Key Statistics
Stock Snapshot
As of today, Amgen(AMGN) shares are valued at $410.85. The company's market cap stands at 220.23B, with a P/E ratio of 25.30 and a dividend yield of 2.44%.
During the trading session on 2026-10-02, Amgen(AMGN) shares reached a daily high of $412.00 and a low of $410.51. At a current price of $410.85, the stock is +0.1% higher than the low and still -0.3% under the high.
Trading volume for Amgen(AMGN) stock has reached 5.12K, versus its average volume of 3.5M.
The stock's 52-week range extends from a low of $288.00 to a high of $447.03.
The stock's 52-week range extends from a low of $288.00 to a high of $447.03.
AMGN News
Amgen Inc (AMGN) announced an update on their ongoing clinical study. Amgen Inc. (AMGN) has completed a Phase 3 study called “A Phase 3, Multicenter, Open-labe...
Amgen (AMGN) is back in focus after reporting positive topline Phase 3 data from its OASIZ 301 trial of dazodalibep in Sjögren's disease, which has sharpened at...
Scotiabank analyst Louise Chen raised the firm’s price target on Amgen (AMGN) to $500 from $450 and keeps an Outperform rating on the shares. The firm notes Amg...
Analyst ratings
51%
of 37 ratingsMore AMGN News
Investing Why Amgen’s 6% Dividend Raise Masks a Tougher Road Ahead Amgen just handed income investors another dividend raise, but a mountain of acquisition debt...
Amgen reported positive topline Phase 3 OASIZ 301 data for dazodalibep in adults with moderate-to-severe systemic Sjögren’s disease, with statistically signific...
In the latest close session, Amgen (AMGN Quick QuoteAMGN - Free Report) was up +2.11% at $414.61. The stock's change was more than the S&P 500's daily gai...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.